Putnam Investments LLC Exelixis, Inc. Transaction History
Putnam Investments LLC
- $73 Billion
- Q4 2023
A detailed history of Putnam Investments LLC transactions in Exelixis, Inc. stock. As of the latest transaction made, Putnam Investments LLC holds 318,097 shares of EXEL stock, worth $11.5 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
318,097
Previous 157,320
102.2%
Holding current value
$11.5 Million
Previous $3.44 Million
122.03%
% of portfolio
0.01%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding EXEL
# of Institutions
468Shares Held
240MCall Options Held
1.87MPut Options Held
1.12M-
Black Rock Inc. New York, NY33.5MShares$1.21 Billion0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA29.7MShares$1.07 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA27.1MShares$982 Million2.95% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny15.2MShares$550 Million0.6% of portfolio
-
State Street Corp Boston, MA12.6MShares$457 Million0.01% of portfolio
About EXELIXIS, INC.
- Ticker EXEL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 321,832,000
- Market Cap $11.7B
- Description
- Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ ...